Product Description: Sulfamerazine-13C6 (RP2632-13C6) is 13C labeled Sulfamerazine (HY-B0512). Sulfamerazine (RP-2632) is a sulfonamide antibacterial. Sulfamerazine, the monomethyl derivative of sulfadiazine, is 2-sulfanilamido-4-methylpyrimidine. Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthesizes.
Applications: COVID-19-immunoregulation
Formula: C5 13C6H12N4O2S
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Aday B, et al. Synthesis of novel sulfonamide analogs containing sulfamerazine/sulfaguanidine and their biological activities. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1005-10.
CAS Number: 1196157-80-8
Molecular Weight: 270.26
Research Area: Infection
Target: Antibiotic;Bacterial;Isotope-Labeled Compounds
Deutsch
English
